Skip to main content

Table 2 Effect of CoQ10 intervention on adipokinesa

From: Coenzyme Q10 supplementation improves adipokine profile in dyslipidemic individuals: a randomized controlled trial

Adipokines

Placebo group

(n = 50)

CoQ10 group

(n = 51)

pb

Adiponectin, ng/mL

 Baseline

5578 (4471, 6939)

5503 (4415, 7561)

0.897

 12 week

5648 (4210, 6847)

5668 (4626, 7740)

0.237

 24 week

5899 (4308, 6842)

5890 (4848, 8224)

0.154

 12-week changec

− 78 (− 308, 65)

165 (0, 362)

 < 0.001

 24-week changed

0.00 (− 288, 145)

523 (0, 1056)

 < 0.001

Leptin, ng/mL

 Baseline

10.35 (5.98, 16.82)

13.43 (6.09, 20.35)

0.446

 12 week

8.37 (6.11, 14.71)

13.98 (6.16, 18.29)

0.156

 24 week

8.28 (6.11, 15.21)

12.34 (5.75, 20.19)

0.153

 12-week change

0.00 (− 1.79, 0.84)

0.00 (− 0.80, 0.86)

0.728

 24-week change

0.00 (− 3.16, 1.77)

0.30 (− 0.10, 3.39)

0.177

Resistin, ng/mL

 Baseline

8.78 (3.79, 14.62)

11.40 (5.67, 14.45)

0.448

 12 week

10.55 (4.48, 15.22)

12.14 (6.26, 14.60)

0.526

 24 week

10.90 (4.56, 16.31)

6.20 (3.15, 13.15)

0.057

 12-week change

0.12 (− 0.45, 1.76)

0.09 (− 0.13, 0.50)

0.868

 24-week change

0.36 (− 0.37, 1.64)

− 1.19 (− 4.35, 0.00)

 < 0.001

  1. avariables are presented as median (with upper and lower quartiles)
  2. bp value from comparison between two groups using Mann–Whitney U test at baseline, week 12, week 24, 12-week change and 24-week change, respectively
  3. c12-week change = adipokine value at week 12—adipokine value at baseline
  4. d24-week change = adipokine value at week 24—adipokine value at baseline